DNAAF5 Gene Primary ciliary dyskinesia type 18 Genetic Test
Components: DNAAF5 Gene Primary ciliary dyskinesia type 18 Genetic Test
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test type: Ear Nose Throat Disorders
Doctor: ENT Doctor
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test gene GJB17
Test Details
The DNAAF5 gene is associated with primary ciliary dyskinesia (PCD) type 18. PCD is a rare genetic disorder that affects the structure and function of cilia, which are hair-like structures on the surface of cells that help with movement and signaling. In PCD, the cilia are abnormal or absent, leading to a variety of symptoms including chronic respiratory infections, hearing loss, and infertility.
NGS genetic testing refers to Next Generation Sequencing, a high-throughput sequencing technology that allows for the simultaneous analysis of multiple genes or even the entire genome. NGS genetic testing can be used to identify mutations or variations in the DNAAF5 gene that are associated with PCD type 18. This type of testing can help with the diagnosis of PCD and provide valuable information for genetic counseling and management of the condition.
It’s important to note that genetic testing should be done under the guidance of a healthcare professional or genetic counselor, as they can help interpret the results and provide appropriate recommendations based on the individual’s specific situation.
| Test Name | DNAAF5 Gene Primary ciliary dyskinesia type 18 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Ear Nose Throat Disorders |
| Doctor | ENT Doctor |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test gene GJB17 |
| Test Details |
The DNAAF5 gene is associated with primary ciliary dyskinesia (PCD) type 18. PCD is a rare genetic disorder that affects the structure and function of cilia, which are hair-like structures on the surface of cells that help with movement and signaling. In PCD, the cilia are abnormal or absent, leading to a variety of symptoms including chronic respiratory infections, hearing loss, and infertility. NGS genetic testing refers to Next Generation Sequencing, a high-throughput sequencing technology that allows for the simultaneous analysis of multiple genes or even the entire genome. NGS genetic testing can be used to identify mutations or variations in the DNAAF5 gene that are associated with PCD type 18. This type of testing can help with the diagnosis of PCD and provide valuable information for genetic counseling and management of the condition. It’s important to note that genetic testing should be done under the guidance of a healthcare professional or genetic counselor, as they can help interpret the results and provide appropriate recommendations based on the individual’s specific situation. |
